- Verastem Oncology Announces Up to $60 Million Private Placement Offering of Series B Convertible Preferred Stock
- Verastem Oncology Announces Positive Data and Regulatory Update from Planned Interim Analysis of Registration-Directed Phase 2 RAMP-201 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
- Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Verastem Oncology Appoints Rob Gagnon to Board of Directors
- Verastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
More ▼
Key statistics
On Thursday, Verastem Inc (VSTM:NMQ) closed at 0.6852, 136.68% above the 52 week low of 0.2895 set on Oct 21, 2022.
52-week range
Markit short selling activity
Open | 0.66 |
---|---|
High | 0.6949 |
Low | 0.65 |
Bid | 0.65 |
Offer | 0.6554 |
Previous close | 0.6349 |
Average volume | 1.04m |
---|---|
Shares outstanding | 210.09m |
Free float | 208.20m |
P/E (TTM) | -- |
Market cap | 133.39m USD |
EPS (TTM) | -0.3952 USD |
Data delayed at least 15 minutes, as of Jan 26 2023 21:00 GMT.
More ▼